Cannabinoid receptor

Structure of CB1 and CB2 receptors.

Cannabinoid receptors are a class of cell membrane receptors under the G protein-coupled receptor (GPCR) superfamily. These receptors are activated by cannabinoids, which are a group of chemical compounds that include the endocannabinoids (produced naturally in the body by humans and animals), the phytocannabinoids (found in cannabis and some other plants), and synthetic cannabinoids (manufactured artificially).

Types of Cannabinoid Receptors

There are two primary types of cannabinoid receptors, known as CB1 and CB2.

CB1 Receptors

CB1 receptors are primarily found in the central nervous system, including the brain and spinal cord. They are also present in some peripheral tissues. CB1 receptors are involved in the modulation of neurotransmitter release, influencing various physiological processes such as pain, appetite, memory, and mood.

CB2 Receptors

CB2 receptors are mainly located in the immune system and associated structures. They play a significant role in modulating immune responses and inflammation. CB2 receptors are also found in some parts of the nervous system, but their functions there are less understood compared to CB1 receptors.

Function

Cannabinoid receptors are involved in a variety of physiological processes. When activated by cannabinoids, these receptors can influence:

• Pain perception
• Appetite regulation
• Mood regulation
• Memory
• Immune function
• Inflammation

The activation of cannabinoid receptors by endocannabinoids is part of the endocannabinoid system, which is crucial for maintaining homeostasis in the body.

Mechanism of Action

Cannabinoid receptors, being part of the GPCR family, work through G proteins. Upon activation by a ligand, such as a cannabinoid, the receptor undergoes a conformational change that activates the associated G protein. This activation leads to a cascade of intracellular events that result in the modulation of various signaling pathways.

Clinical Significance

Cannabinoid receptors are targets for the development of therapeutic agents. Drugs that modulate the activity of these receptors are being researched for their potential in treating conditions such as:

• Chronic pain
• Multiple sclerosis
• Epilepsy
• Cancer
• Anxiety disorders

Related Pages

• Endocannabinoid system
• Cannabis
• G protein-coupled receptor
• Neurotransmitter

• Human Cannabinoid Receptor 1 (CB1)
  Human Cannabinoid Receptor 1 (CB1)
• Human Cannabinoid Receptor 2 (CB2)
  Human Cannabinoid Receptor 2 (CB2)